Atopic dermatitis: immunobiology and treatment with immune modulators

Area of Science:

• Immunology
• Dermatology
• Genetics

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin disease often co-occurring with asthma and allergic rhinitis.
• Its prevalence is increasing, particularly in children, significantly impacting quality of life.
• The term 'atopic dermatitis' highlights its connection to respiratory allergies.

Purpose of the Study:

• To review the cellular and immunological mechanisms underlying chronic AD pathogenesis.
• To explore the genetic and environmental factors contributing to AD development.
• To discuss the implications for managing AD and developing immunomodulators.

Main Methods:

• Review of current literature on AD immunopathogenesis.
• Analysis of genetic factors, including cytokine gene activation (IL-3, IL-4, IL-5, IL-13, GM-CSF).
• Examination of host-environment interactions and immune cell trafficking.

Main Results:

• Allergic diseases, including AD, involve polygenic inheritance and specific cytokine gene cluster activation.
• Clinical manifestation depends on genetic predisposition, environmental factors like allergen exposure, and immune cell homing.
• Differences in immune responses between skin and respiratory mucosa influence disease presentation.

Conclusions:

• Understanding the immunological basis of AD is crucial for effective management.
• Advances in understanding immunopathogenesis pave the way for novel immunomodulatory treatments.
• Targeting specific immune pathways holds promise for treating chronic atopic dermatitis.